🇺🇸 Summit Therapeutics Inc.SMMT
Get Summit Therapeutics Inc. filings on Telegram the moment they are published.
Follow Summit Therapeutics Inc. on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 8-K Items 8.01, 9.01
Overview: The FDA issued a Complete Response Letter regarding the BLA for ivonescimab in combination with chemotherapy for certain NSCLC patients.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest